HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 35, 25001-25005, September 1, 2006

This Article Full Text (PDF) All Versions of this Article: 281/35/25001    most recent R600010200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pewzner-Jung, Y. Articles by Futerman, A. H. Search for Related Content PubMed PubMed Citation Articles by Pewzner-Jung, Y. Articles by Futerman, A. H. Social Bookmarking                      What's this?

Minireview

When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?

INSIGHTS INTO THE REGULATION OF CERAMIDE SYNTHESIS^*

Yael Pewzner-Jung, Shifra Ben-Dor, and Anthony H. Futerman¹

From the Departments of Biological Chemistry and Biological Services, Weizmann Institute of Science, Rehovot 76100, Israel

	INTRODUCTION

TOP INTRODUCTION Molecular Identification of... Roles of Ceramides Containing... Perspectives REFERENCES

 
Ceramide is the key intermediate in the pathway of sphingolipid (SL)² biosynthesis (1) and an important intracellular signaling molecule (2, 3). Ceramide consists of a sphingoid long chain base to which a fatty acid is attached via an amide bond (Fig. 1). When the chemical composition of SLs was first determined in the 1940s (4), stearic acid (C18:0) was identified as the major fatty acid attached to the sphingoid base. Later, with the development of more sensitive techniques (5, 6), it became clear that mammalian SLs contain a wide variety of fatty acids, ranging in length from C14 to C32, that are predominantly saturated and can contain - or -hydroxyl groups (7, 8). Within the past few years, there has been renewed interest in the functional significance of this fatty acid variability, and this minireview will focus on current advances in our understanding of how the fatty acid composition of ceramide is regulated. In particular, we will discuss a recently discovered family of mammalian ceramide synthase (CerS) genes and emerging evidence that specific ceramides containing distinct fatty acids play important roles in cell growth and apoptosis.

	Molecular Identification of Ceramide Synthases

TOP INTRODUCTION Molecular Identification of... Roles of Ceramides Containing... Perspectives REFERENCES

 
CerS acylates sphinganine (dihydrosphingosine) to form dihydroceramide and sphingosine to form ceramide; sphinganine is produced through the de novo biosynthetic pathway and sphingosine mainly through SL degradation (1, 9). Early studies detected CerS activity in microsomal fractions, and the enzyme was shown to utilize a variety of fatty acyl-CoAs although some specificity toward certain CoAs was recognized (10). CerS activity was later localized to the cytoplasmic leaflet of the endoplasmic reticulum (ER) (11, 12).

The first clue to the molecular identity of CerS was obtained in yeast, when it was shown that Lag1p and Lac1p were required for the synthesis of C26-ceramide (13, 14).³ Lag1 was originally isolated in a screen for longevity-related genes (15). A paralog,⁴ Lac1, was found in a data base screen (16) along with homologs in human, mouse, and Caenorhabditis elegans. The Asc1 gene in tomato was subsequently isolated as a toxin-resistant gene (17); among the toxins tested was fumonisin B1, a CerS inhibitor (18). Homologs of Lag1 and Lac1 have now been found in most species. Six paralogs are known in human and mouse, and were named Lass (longevity assurance) genes; in all species studied to date, at least two genes have been found in every organism.

All of the Lass genes have a distinguishing motif in the C-terminal portion of the protein. This motif has been defined in a narrow but specific manner as the Lag domain, a region of 50 amino acid residues (19), and in a broader manner as the Tram-Lag-CLN8 (TLC) domain, a region of 200 residues also found in other proteins (20). The broader definition is based on two additional proteins, TRAM1 and CLN8; TRAM1 was found in a search for homologs of Lag1 in humans. The exact function of TRAM proteins is not known, but they are thought to be involved in polypeptide transition through the ER (21, 22). CLN8 was found by screening for genes causing neuronal ceroid-lipofuscinosis (23), an inherited metabolic disorder (24). Both TRAM1 (13) and CLN8 (25) failed to complement the yeast Lag1/Lac1 knock-out, suggesting that the TLC domain is not sufficient for CerS activity, whereas some human LASS proteins tested were able to complement CerS activity (25, 26).

In humans there are 16 TLC domain-containing genes (Fig. 2): six LASSes, three TRAMs, CLN8, and six other novel genes. All 16 genes are conserved in mouse. When the 16 human proteins are aligned, four distinct branches appear. FAM57A and -B are one subgroup and are closer to CLN8 and the other novel proteins than to LASSes and TRAMs. The TRAM proteins form their own subgroup but are relatively close to the LASSes. The LASSes subdivide into two distinct groups, with LASS1 in its own category and LASSes 2–6 on a separate branch. This is consistent with the fact that LASS1 is much closer to the yeast proteins than the others (27).

A subset of Lass genes is predicted to contain a Homeobox (Hox) domain (19). In humans and mice, all but Lass1 have a Hox domain, in Drosophila only one of the four TLC-containing genes have a Hox domain, and no Hox domains are found in yeast and plant Lass genes. The Hox domain is derived from homeobox proteins, which are sequence-specific transcription factors important in development (28), but there is no evidence that the Hox domain in Lass genes acts as a transcription factor. The fact that many family members lack the Hox domain suggest that it is unlikely to be involved in the catalytic mechanism of CerS.

The six human LASS genes are located on different chromosomes (with the exception of LASS1 and -4, which are located on the same chromosome but at distant locations). Human and mouse orthologs⁴ show strong similarity both in sequence and genomic structure, with the two major domains (i.e. Hox and TLC) encoded by the same relative exon in each of the LASS genes. All six genes in human (except, to date, LASS3) encode at least two isoforms, one of which lacks the homeobox domain and part of the TLC domain; the relevance of these short isoforms is currently unknown but may imply similar mechanisms of transcriptional regulation. Fig. 3 shows the genomic organization and protein isoforms of one of the LASS genes, namely LASS2. Recently, a splice variant of LASS5 has been shown to be expressed in lymphoma and other tumor cells and may be involved in tumor recognition by the immune system (29).

View larger version (8K): [in this window] [in a new window]   FIGURE 1. Structure of ceramide. Ceramide consists of a sphingoid long chain base (shown in black), normally sphingosine, dihydrosphingosine (sphinganine), or 4-hydroxysphinganine (phytosphingosine), to which a fatty acid (shown in blue) is attached via an amide bond at C-2. The sphingoid base in the figure is sphingosine (which differs from sphinganine inasmuch as it contains a trans 4–5 double bond). Naturally occurring ceramide exists in the D-erythro conformation (2S, 3R). The fatty acid in the figure is palmitic acid, one of the major fatty acids found in ceramide, but ceramides contain a wide spectrum of fatty acids.

The yeast genes, Lag1 and Lac1, act in an obligate complex with an additional protein, Lip1 (33), an integral ER membrane protein with one predicted TM domain. The Lip1 regions required for CerS activity may be in the membrane or in the lumen of the ER. Mammalian homologs of Lip1 have not been found in data base searches. The activity of mammalian Lass proteins might conceivably be regulated by other TLC family members (34).

The first evidence for specific functional roles of mammalian Lass genes was obtained upon overexpression of LASS1 (formerly known as UOG1), which resulted in a selective increase in C18-ceramide in mammalian cells (31). LASS4 (TRH1) and LASS5 (TRH4) were subsequently shown to selectively utilize C18/20 and C16 acyl-CoAs, respectively (32), LASS6 to produce shorter acyl chain ceramides (C14 and C16) (27), and LASS3 to produce C18- and C24-ceramides (35), although the surprisingly high levels of C18-ceramide synthesis are at variance with other analyses.⁵ Verification that mammalian LASS proteins are bona fide ceramide synthases, rather than regulators of endogenous ceramide synthases, was obtained when purified LASS5 was shown to possess CerS activity (36). Together with the CerS activity of the purified Lag1-Lac1-Lip1 complex in yeast (33), this supports the concept that LASS proteins are genuine ceramide synthases, with each mammalian protein utilizing a relatively restricted subset of fatty acyl-CoAs. It is assumed that the six known mammalian LASS proteins account for the synthesis of all known ceramides, but the possibility cannot be excluded that some other proteins, such as ceramidases (37), may also contribute to the synthesis of ceramides with restricted fatty acid composition.

View larger version (22K): [in this window] [in a new window]   FIGURE 2. Phylogenetic tree of the 16 human TLC domain-containing proteins. Sequences were taken from Swiss-Prot with the exception of H17C473.1, which does not have a full-length mRNA in human and is based on a gene model from Ecgene and which closely matches the mouse cDNA available for the gene. Alignment was performed using ClustalW (version 1.82). One hundred data sets were created by Seqboot in the Phylip package (version 3.65). The trees were built with Proml (maximum likelihood, Phylip package), and a consensus tree was constructed by Consense (Phylip). A tree with the same topology was obtained using Neighbor Joining (in ClustalW) with 1000 bootstrap values. The tree was colored on the branches with bootstrap values of 1000. The non-colored branches had insignificant bootstrap values.

	Roles of Ceramides Containing Distinct Fatty Acids

TOP INTRODUCTION Molecular Identification of... Roles of Ceramides Containing... Perspectives REFERENCES

View larger version (22K): [in this window] [in a new window]   FIGURE 3. Genomic organization, mRNA transcripts, and protein isoforms of human LASS2. The genomic organization of LASS2 was obtained using the UCSC Genome Bioinformatics web site. a, exon coding sequences are colored, and non-coding regions are in dark blue. b, mRNA transcripts are color-coded as in the scheme of the genomic DNA. Non-coding exons are in black. All four transcripts have identical open reading frames and therefore encode the same LASS2 isoform. In the scheme of the protein, the colored regions correspond to the exons shown in a; the numbers below the protein indicate the amino acid residues at the beginning and end of these regions, and the Homeobox and TLC domains are indicated as predicted by Prosite. c, two additional mRNA transcripts are shown together with the corresponding protein isoform.

View larger version (16K): [in this window] [in a new window]   FIGURE 4. Phenogram, predicted domains, and proposed new terminology of human CerS proteins. The phenogram shows the relationship between LASS proteins. The suggested new terminology (CerS) is indicated. Protein domains are as predicted by Prosite; the Homeobox domain is in blue, and the TLC domain is in orange. Numbers represent the amino acid residues at the beginning and end of these regions.

C16-ceramide is one of the major ceramide species in non-neuronal tissues and has been suggested to be the predominant species elevated during apoptosis under a broad spectrum of stimuli (44–49). For instance, C16-ceramide, derived from sphingomyelin, increases during tumor necrosis factor -induced apoptosis in primary hepatocytes (46), whereas C16-ceramide derived from de novo synthesis is elevated in androgen ablation-induced apoptosis of LNCaP prostate cancer cells (45) and during B cell receptor engagement on Ramos cells (48). C24-ceramide also increases in Ramos cells but not until 24 h after B cell receptor engagement, whereas C16-ceramide is elevated after 6 h (47). A similar temporal pattern was observed in androgen-insensitive DU145 prostate cancer cells in which C16-ceramide was elevated after 24 h and C24-ceramide after 48 h (49). Changes in C16- and C24-ceramide levels via the de novo pathway have also been observed in bone marrow-derived dendritic cells (50). In apparent contrast, tumor cells, such as head and neck squamous cell carcinoma (51), Sarcoma 180, B16 melanoma, and Lewis lung carcinoma cells (52), contain high levels of C16-ceramide, suggesting that C16-ceramide might also be able to promote cell growth. It is therefore notclearifC16-ceramideispro-apoptotic, or alternatively, whether it is the delayed elevation of C24-ceramide or another ceramide species that is involved in cell death. A possible role of C18-ceramide in growth arrest was also suggested because levels of C18-ceramide were decreased in head and neck squamous cell carcinoma samples, and overexpression of LASS1 increased C18-ceramide levels and inhibited cell growth (51). Thus, at present, it is difficult to draw definitive conclusions concerning the role of particular ceramides in defined physiological and pathophysiological events. However, the availability of the Lass genes and the possibility to experimentally manipulate their expression, will permit dissection of the precise roles of specific ceramide species.

How might ceramides containing different fatty acids impact upon cell physiology? One or more biophysical properties of the membrane lipid bilayer could be influenced by the fatty acid composition of ceramide (53). Alternatively, specific ceramides could directly interact with downstream components in signaling pathways. In both scenarios, regulation of the activity of the Lass genes (for instance by transcriptional or post-translational mechanisms) would be an important and novel mode of controlling the fatty acid composition of ceramides. However, very little is known about the relationship between levels of specific ceramides and the activity of Lass genes in different cells. Early work implied post-translational modification of CerS (39, 54), and the restricted tissue distribution of Lass genes (32, 55) is consistent with multiple levels of regulation of CerS. For instance, the mRNA of Lass3 is expressed at high levels in skin (32), which contains very long acyl chain ceramides that are involved in maintaining the water permeability barrier function of skin (56).

	Perspectives

TOP INTRODUCTION Molecular Identification of... Roles of Ceramides Containing... Perspectives REFERENCES

 
The unexpected discovery of a family of genes involved in regulating the fatty acid composition of ceramides is likely to lead to a new level of understanding of the complexity of ceramide biology (3, 57). Many open questions remain concerning the function and mode of regulation of the Lass genes themselves. For instance, what is the role of the TLC domain and why are there so many TLC domain-containing proteins (Fig. 2) with only some appearing to meet the criteria to be characterized as genuine ceramide synthases? What are the functions of the other family members? Do they act as regulators of the CerS proteins or do they have unrelated functions? What are the functions of the splice variants (Fig. 3) and might they act in a dominant-negative fashion to modify the activity of full-length Lass genes? Finally, when do Lasses become CerS (Fig. 4)? What are the critical regions in the LASS proteins that confer ceramide synthase activity? What are the regions responsible for acyl-CoA and sphingoid base selectivity and how are these regions conserved or how do they differ between the different LASS proteins? Irrespective of the answers to these and other questions, all the available evidence strongly implies that the key attribute of Lass genes is their ceramide synthase activity rather than their role in longevity. This being the case, we propose renaming the six Lass genes as CerS1–6 (Fig. 4), to more accurately reflect their known function.

	FOOTNOTES

 
^* This minireview will be reprinted in the 2006 Minireview Compendium, which will be available in January, 2007.

¹ Joseph Meyerhoff Professor of Biochemistry at Weizmann Institute of Science. To whom correspondence should be addressed. Tel.: 972-8-9342704; Fax: 972-8-9344112; E-mail: tony.futerman{at}weizmann.ac.il.

² The abbreviations used are: SL, sphingolipid; CerS, ceramide synthase; ER, endoplasmic reticulum; TM, trans-membrane.

³ In contrast to mammalian cells, yeast SLs contain mainly C26-fatty acid.

⁴ Paralogs are parallel genes in the same species, and an ortholog (see below) is the same gene in different species; homolog is a term encompassing both ortholog and paralog.

⁵ I. Pankova-Kholmyansky, S. Epstein, E. Wang, J. C. Allegood, S. Kelly, A. H. Merrill, Jr., and A. H. Futerman, unpublished observations.

	REFERENCES

TOP INTRODUCTION Molecular Identification of... Roles of Ceramides Containing... Perspectives REFERENCES

 

1. Merrill, A. H., Jr. (2002) J. Biol. Chem. 277, 25843–25846[Free Full Text]
2. Kolesnick, R. (2002) J. Clin. Invest. 110, 3–8[CrossRef][Medline] [Order article via Infotrieve]
3. Hannun, Y. A., and Obeid, L. M. (2002) J. Biol. Chem. 277, 25847–25850[Free Full Text]
4. Klenk, E. Z. (1942) Physiol. Chem. 273, 76–86
5. Trams, E. G., Giuffrida, L. E., and Karmen, A. (1962) Nature 193, 680–681[CrossRef][Medline] [Order article via Infotrieve]
6. O'Brien, J. S., Fillerup, D. L., and Mead, J. F. (1964) J. Lipid Res. 15, 109–116[Medline] [Order article via Infotrieve]
7. van Meer, G. (2005) EMBO J. 24, 3159–3165[CrossRef][Medline] [Order article via Infotrieve]
8. Merrill, A. H., Jr., Sullards, M. C., Allegood, J. C., Kelly, S., and Wang, E. (2005) Methods 36, 207–224[CrossRef][Medline] [Order article via Infotrieve]
9. Futerman, A. H., and Riezman, H. (2005) Trends Cell Biol. 15, 312–318[CrossRef][Medline] [Order article via Infotrieve]
10. Morell, P., and Radin, N. S. (1970) J. Biol. Chem. 245, 342–350[Abstract/Free Full Text]
11. Mandon, E. C., Ehses, I., Rother, J., Van Echten, G., and Sandhoff, K. (1992) J. Biol. Chem. 267, 11144–11148[Abstract/Free Full Text]
12. Hirschberg, K., Rodger, J., and Futerman, A. H. (1993) Biochem. J. 290, 751–757[Medline] [Order article via Infotrieve]
13. Guillas, I., Kirchman, P. A., Chuard, R., Pfefferli, M., Jiang, J. C., Jazwinski, S. M., and Conzelmann, A. (2001) EMBO J. 20, 2655–2665[CrossRef][Medline] [Order article via Infotrieve]
14. Schorling, S., Vallee, B., Barz, W. P., Riezman, H., and Oesterhelt, D. (2001) Mol. Biol. Cell 12, 3417–3427[Abstract/Free Full Text]
15. D'Mello, N. P., Childress, A. M., Franklin, D. S., Kale, S. P., Pinswasdi, C., and Jazwinski, S. M. (1994) J. Biol. Chem. 269, 15451–15459[Abstract/Free Full Text]
16. Jiang, J. C., Kirchman, P. A., Zagulski, M., Hunt, J., and Jazwinski, S. M. (1998) Genome Res. 8, 1259–1272[Abstract/Free Full Text]
17. Brandwagt, B. F., Mesbah, L. A., Takken, F. L., Laurent, P. L., Kneppers, T. J., Hille, J., and Nijkamp, H. J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4961–4966[Abstract/Free Full Text]
18. Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T., and Merrill, A. H. (1991) J. Biol. Chem. 266, 14486–14490[Abstract/Free Full Text]
19. Venkataraman, K., and Futerman, A. (2002) FEBS Lett. 528, 3–4[CrossRef][Medline] [Order article via Infotrieve]
20. Winter, E., and Ponting, C. P. (2002) Trends Biochem. Sci. 27, 381–383[CrossRef][Medline] [Order article via Infotrieve]
21. Gorlich, D., Hartmann, E., Prehn, S., and Rapoport, T. A. (1992) Nature 357, 47–52[CrossRef][Medline] [Order article via Infotrieve]
22. Rapoport, T. A. (1992) Science 258, 931–936[Abstract/Free Full Text]
23. Ranta, S., Zhang, Y., Ross, B., Lonka, L., Takkunen, E., Messer, A., Sharp, J., Wheeler, R., Kusumi, K., Mole, S., Liu, W., Soares, M. B., Bonaldo, M. F., Hirvasniemi, A., de la Chapelle, A., Gilliam, T. C., and Lehesjoki, A. E. (1999) Nat. Genet. 23, 233–236[CrossRef][Medline] [Order article via Infotrieve]
24. Futerman, A. H., and van Meer, G. (2004) Nat. Rev. Mol. Cell Biol. 5, 554–565[CrossRef][Medline] [Order article via Infotrieve]
25. Guillas, I., Jiang, J. C., Vionnet, C., Roubaty, C., Uldry, D., Chuard, R., Wang, J., Jazwinski, S. M., and Conzelmann, A. (2003) J. Biol. Chem. 278, 37083–37091[Abstract/Free Full Text]
26. Yu, Y., Lu, H., Pan, H., Ma, J. H., Ding, Z. J., and Li, Y. Y. (2006) Microbiol. Res. 161, 203–211[CrossRef][Medline] [Order article via Infotrieve]
27. Mizutani, Y., Kihara, A., and Igarashi, Y. (2005) Biochem. J. 390, 263–271[CrossRef][Medline] [Order article via Infotrieve]
28. Gehring, W. J. (1993) Gene (Amst.) 135, 215–221[CrossRef][Medline] [Order article via Infotrieve]
29. van Hall, T., Wolpert, E. Z., van Veelen, P., Laban, S., van der Veer, M., Roseboom, M., Bres, S., Grufman, P., de Ru, A., Meiring, H., de Jong, A., Franken, K., Teixeira, A., Valentijn, R., Drijfhout, J. W., Koning, F., Camps, M., Ossendorp, F., Karre, K., Ljunggren, H. G., Melief, C. J., and Offringa, R. (2006) Nat. Med. 12, 417–424[CrossRef][Medline] [Order article via Infotrieve]
30. Kageyama-Yahara, N., and Riezman, H. (2006) Biochem. J., in press
31. Venkataraman, K., Riebeling, C., Bodennec, J., Riezman, H., Allegood, J. C., Sullards, M. C., Merrill, A. H., Jr., and Futerman, A. H. (2002) J. Biol. Chem. 277, 35642–35649[Abstract/Free Full Text]
32. Riebeling, C., Allegood, J. C., Wang, E., Merrill, A. H., Jr., and Futerman, A. H. (2003) J. Biol. Chem. 278, 43452–43459[Abstract/Free Full Text]
33. Vallee, B., and Riezman, H. (2005) EMBO J. 24, 730–741[CrossRef][Medline] [Order article via Infotrieve]
34. Schulz, A., Mousallem, T., Venkataramani, M., Persaud-Sawin, D. A., Zucker, A., Luberto, C., Bielawska, A., Bielawski, J., Holthuis, J. C., Jazwinski, S. M., Kozhaya, L., Dbaibo, G. S., and Boustany, R. M. (2006) J. Biol. Chem. 281, 2784–2794[Abstract/Free Full Text]
35. Mizutani, Y., Kihara, A., and Igarashi, Y. (2006) Biochem. J., in press
36. Lahiri, S., and Futerman, A. H. (2005) J. Biol. Chem. 280, 33735–33738[Abstract/Free Full Text]
37. El Bawab, S., Birbes, H., Roddy, P., Szulc, Z. M., Bielawska, A., and Hannun, Y. A. (2001) J. Biol. Chem. 276, 16758–16766[Abstract/Free Full Text]
38. Lynch, D. V., and Dunn, T. M. (2004) New Phytol. 161, 677–702[CrossRef]
39. Yano, M., Kishida, E., Muneyuki, Y., and Masuzawa, Y. (1998) J. Lipid Res. 39, 2091–2098[Abstract/Free Full Text]
40. Esch, S. W., Williams, T. D., Biswas, S., Chakrabarty, A., and Levine, S. M. (2003) Cell Mol. Biol. 49, 779–787[Medline] [Order article via Infotrieve]
41. Perry, D. K. (2000) Ann. N. Y. Acad. Sci. 905, 91–96[Medline] [Order article via Infotrieve]
42. Cowart, L. A., Okamoto, Y., Lu, X., and Hannun, Y. A. (2006) Biochem. J. 393, 733–740[CrossRef][Medline] [Order article via Infotrieve]
43. Liao, W. C., Haimovitz-Friedman, A., Persaud, R. S., McLoughlin, M., Ehleiter, D., Zhang, N., Gatei, M., Lavin, M., Kolesnick, R., and Fuks, Z. (1999) J. Biol. Chem. 274, 17908–17917[Abstract/Free Full Text]
44. Thomas, R. L., Jr., Matsko, C. M., Lotze, M. T., and Amoscato, A. A. (1999) J. Biol. Chem. 274, 30580–30588[Abstract/Free Full Text]
45. Eto, M., Bennouna, J., Hunter, O. C., Hershberger, P. A., Kanto, T., Johnson, C. S., Lotze, M. T., and Amoscato, A. A. (2003) Prostate 57, 66–79[CrossRef][Medline] [Order article via Infotrieve]
46. Osawa, Y., Uchinami, H., Bielawski, J., Schwabe, R. F., Hannun, Y. A., and Brenner, D. A. (2005) J. Biol. Chem. 280, 27879–27887[Abstract/Free Full Text]
47. Kroesen, B. J., Jacobs, S., Pettus, B. J., Sietsma, H., Kok, J. W., Hannun, Y. A., and de Leij, L. F. (2003) J. Biol. Chem. 278, 14723–14731[Abstract/Free Full Text]
48. Kroesen, B. J., Pettus, B., Luberto, C., Busman, M., Sietsma, H., de Leij, L., and Hannun, Y. A. (2001) J. Biol. Chem. 276, 13606–13614[Abstract/Free Full Text]
49. Eto, M., Bennouna, J., Hunter, O. C., Lotze, M. T., and Amoscato, A. A. (2006) Int. J. Urol. 13, 148–156[CrossRef][Medline] [Order article via Infotrieve]
50. Kanto, T., Kalinski, P., Hunter, O. C., Lotze, M. T., and Amoscato, A. A. (2001) J. Immunol. 167, 3773–3784[Abstract/Free Full Text]
51. Koybasi, S., Senkal, C. E., Sundararaj, K., Spassieva, S., Bielawski, J., Osta, W., Day, T. A., Jiang, J. C., Jazwinski, S. M., Hannun, Y. A., Obeid, L. M., and Ogretmen, B. (2004) J. Biol. Chem. 279, 44311–44319[Abstract/Free Full Text]
52. Koyanagi, S., Kuga, M., Soeda, S., Hosoda, Y., Yokomatsu, T., Takechi, H., Akiyama, T., Shibuya, S., and Shimeno, H. (2003) Int. J. Cancer 105, 1–6[CrossRef][Medline] [Order article via Infotrieve]
53. Sot, J., Aranda, F. J., Collado, M. I., Goni, F. M., and Alonso, A. (2005) Biophys. J. 88, 3368–3380[CrossRef][Medline] [Order article via Infotrieve]
54. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R. (1995) Cell 82, 405–414[CrossRef][Medline] [Order article via Infotrieve]
55. Xu, Z., Zhou, J., McCoy, D. M., and Mallampalli, R. K. (2005) J. Lipid Res. 46, 1229–1238[Abstract/Free Full Text]
56. Coderch, L., Lopez, O., de la Maza, A., and Parra, J. L. (2003) Am. J. Clin. Dermatol. 4, 107–129[CrossRef][Medline] [Order article via Infotrieve]
57. Futerman, A. H., and Hannun, Y. A. (2004) EMBO Rep. 5, 777–782[CrossRef][Medline] [Order article via Infotrieve]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				G. Yang, L. Badeanlou, J. Bielawski, A. J. Roberts, Y. A. Hannun, and F. Samad Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E211 - E224. [Abstract] [Full Text] [PDF]

				H. Hamai, F. Keyserman, L. M. Quittell, and T. S. Worgall Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling J. Lipid Res., June 1, 2009; 50(6): 1101 - 1108. [Abstract] [Full Text] [PDF]

				S. Schiffmann, J. Sandner, K. Birod, I. Wobst, C. Angioni, E. Ruckhaberle, M. Kaufmann, H. Ackermann, J. Lotsch, H. Schmidt, et al. Ceramide synthases and ceramide levels are increased in breast cancer tissue Carcinogenesis, May 1, 2009; 30(5): 745 - 752. [Abstract] [Full Text] [PDF]

				V. Menuz, K. S. Howell, S. Gentina, S. Epstein, I. Riezman, M. Fornallaz-Mulhauser, M. O. Hengartner, M. Gomez, H. Riezman, and J.-C. Martinou Protection of C. elegans from Anoxia by HYL-2 Ceramide Synthase Science, April 17, 2009; 324(5925): 381 - 384. [Abstract] [Full Text] [PDF]

				N. Bartke and Y. A. Hannun Bioactive sphingolipids: metabolism and function J. Lipid Res., April 1, 2009; 50(Supplement): S91 - S96. [Abstract] [Full Text] [PDF]

				A. H. Merrill Jr., T. H. Stokes, A. Momin, H. Park, B. J. Portz, S. Kelly, E. Wang, M. C. Sullards, and M. D. Wang Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease J. Lipid Res., April 1, 2009; 50(Supplement): S97 - S102. [Abstract] [Full Text] [PDF]

				A. Mukhopadhyay, S. A. Saddoughi, P. Song, I. Sultan, S. Ponnusamy, C. E. Senkal, C. F. Snook, H. K. Arnold, R. C. Sears, Y. A. Hannun, et al. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling FASEB J, March 1, 2009; 23(3): 751 - 763. [Abstract] [Full Text] [PDF]

				E. V. Berdyshev, I. Gorshkova, A. Skobeleva, R. Bittman, X. Lu, S. M. Dudek, T. Mirzapoiazova, J. G. N. Garcia, and V. Natarajan FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells J. Biol. Chem., February 27, 2009; 284(9): 5467 - 5477. [Abstract] [Full Text] [PDF]

				N. C. Zitomer, T. Mitchell, K. A. Voss, G. S. Bondy, S. T. Pruett, E. C. Garnier-Amblard, L. S. Liebeskind, H. Park, E. Wang, M. C. Sullards, et al. Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine: A NOVEL CATEGORY OF BIOACTIVE 1-DEOXYSPHINGOID BASES AND 1-DEOXYDIHYDROCERAMIDES BIOSYNTHESIZED BY MAMMALIAN CELL LINES AND ANIMALS J. Biol. Chem., February 20, 2009; 284(8): 4786 - 4795. [Abstract] [Full Text] [PDF]

				S. Schiffmann, J. Sandner, R. Schmidt, K. Birod, I. Wobst, H. Schmidt, C. Angioni, G. Geisslinger, and S. Grosch The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis J. Lipid Res., January 1, 2009; 50(1): 32 - 40. [Abstract] [Full Text] [PDF]

				Y. Mizutani, A. Kihara, H. Chiba, H. Tojo, and Y. Igarashi 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length J. Lipid Res., November 1, 2008; 49(11): 2356 - 2364. [Abstract] [Full Text] [PDF]

				D. A. Chudakova, Y. H. Zeidan, B. W. Wheeler, J. Yu, S. A. Novgorodov, M. S. Kindy, Y. A. Hannun, and T. I. Gudz Integrin-associated Lyn Kinase Promotes Cell Survival by Suppressing Acid Sphingomyelinase Activity J. Biol. Chem., October 24, 2008; 283(43): 28806 - 28816. [Abstract] [Full Text] [PDF]

				X. Deng, X. Yin, R. Allan, D. D. Lu, C. W. Maurer, A. Haimovitz-Friedman, Z. Fuks, S. Shaham, and R. Kolesnick Ceramide Biogenesis Is Required for Radiation-Induced Apoptosis in the Germ Line of C. elegans Science, October 3, 2008; 322(5898): 110 - 115. [Abstract] [Full Text] [PDF]

				S. T. Pruett, A. Bushnev, K. Hagedorn, M. Adiga, C. A. Haynes, M. C. Sullards, D. C. Liotta, and A. H. Merrill Jr. Thematic Review Series: Sphingolipids. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols J. Lipid Res., August 1, 2008; 49(8): 1621 - 1639. [Abstract] [Full Text] [PDF]

				M. Chen, J. E. Markham, C. R. Dietrich, J. G. Jaworski, and E. B. Cahoon Sphingolipid Long-Chain Base Hydroxylation Is Important for Growth and Regulation of Sphingolipid Content and Composition in Arabidopsis PLANT CELL, July 1, 2008; 20(7): 1862 - 1878. [Abstract] [Full Text] [PDF]

				W. L. Holland and S. A. Summers Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism Endocr. Rev., June 1, 2008; 29(4): 381 - 402. [Abstract] [Full Text] [PDF]

				C. Shah, G. Yang, I. Lee, J. Bielawski, Y. A. Hannun, and F. Samad Protection from High Fat Diet-induced Increase in Ceramide in Mice Lacking Plasminogen Activator Inhibitor 1 J. Biol. Chem., May 16, 2008; 283(20): 13538 - 13548. [Abstract] [Full Text] [PDF]

				R. C. Dickson Thematic Review Series: Sphingolipids. New insights into sphingolipid metabolism and function in budding yeast J. Lipid Res., May 1, 2008; 49(5): 909 - 921. [Abstract] [Full Text] [PDF]

				E. L. Laviad, L. Albee, I. Pankova-Kholmyansky, S. Epstein, H. Park, A. H. Merrill Jr., and A. H. Futerman Characterization of Ceramide Synthase 2: TISSUE DISTRIBUTION, SUBSTRATE SPECIFICITY, AND INHIBITION BY SPHINGOSINE 1-PHOSPHATE J. Biol. Chem., February 29, 2008; 283(9): 5677 - 5684. [Abstract] [Full Text] [PDF]

				E. N. Maldonado, N. L. Alderson, P. V. Monje, P. M. Wood, and H. Hama FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin J. Lipid Res., January 1, 2008; 49(1): 153 - 161. [Abstract] [Full Text] [PDF]

				H. Le Stunff, P. Giussani, M. Maceyka, S. Lepine, S. Milstien, and S. Spiegel Recycling of Sphingosine Is Regulated by the Concerted Actions of Sphingosine-1-phosphate Phosphohydrolase 1 and Sphingosine Kinase 2 J. Biol. Chem., November 23, 2007; 282(47): 34372 - 34380. [Abstract] [Full Text] [PDF]

				D. Halter, S. Neumann, S. M. van Dijk, J. Wolthoorn, A. M. de Maziere, O. V. Vieira, P. Mattjus, J. Klumperman, G. van Meer, and H. Sprong Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis J. Cell Biol., October 8, 2007; 179(1): 101 - 115. [Abstract] [Full Text] [PDF]

				L. G. Wooten-Blanks, P. Song, C. E. Senkal, and B. Ogretmen Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1 FASEB J, October 1, 2007; 21(12): 3386 - 3397. [Abstract] [Full Text] [PDF]

				A. Mesika, S. Ben-Dor, E. L. Laviad, and A. H. Futerman A New Functional Motif in Hox Domain-containing Ceramide Synthases: IDENTIFICATION OF A NOVEL REGION FLANKING THE Hox AND TLC DOMAINS ESSENTIAL FOR ACTIVITY J. Biol. Chem., September 14, 2007; 282(37): 27366 - 27373. [Abstract] [Full Text] [PDF]

				J. Min, A. Mesika, M. Sivaguru, P. P. Van Veldhoven, H. Alexander, A. H. Futerman, and S. Alexander (Dihydro)ceramide Synthase 1 Regulated Sensitivity to Cisplatin Is Associated with the Activation of p38 Mitogen-Activated Protein Kinase and Is Abrogated by Sphingosine Kinase 1 Mol. Cancer Res., August 1, 2007; 5(8): 801 - 812. [Abstract] [Full Text] [PDF]

				N. E. Furland, S. R. Zanetti, G. M. Oresti, E. N. Maldonado, and M. I. Aveldano Ceramides and Sphingomyelins with High Proportions of Very Long-chain Polyunsaturated Fatty acids in Mammalian Germ Cells J. Biol. Chem., June 22, 2007; 282(25): 18141 - 18150. [Abstract] [Full Text] [PDF]

				Y. Baran, A. Salas, C. E. Senkal, U. Gunduz, J. Bielawski, L. M. Obeid, and B. Ogretmen Alterations of Ceramide/Sphingosine 1-Phosphate Rheostat Involved in the Regulation of Resistance to Imatinib-induced Apoptosis in K562 Human Chronic Myeloid Leukemia Cells J. Biol. Chem., April 13, 2007; 282(15): 10922 - 10934. [Abstract] [Full Text] [PDF]

				C. E. Senkal, S. Ponnusamy, M. J. Rossi, J. Bialewski, D. Sinha, J. C. Jiang, S. M. Jazwinski, Y. A. Hannun, and B. Ogretmen Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas Mol. Cancer Ther., February 1, 2007; 6(2): 712 - 722. [Abstract] [Full Text] [PDF]

				F. G. Tafesse, P. Ternes, and J. C. M. Holthuis The Multigenic Sphingomyelin Synthase Family J. Biol. Chem., October 6, 2006; 281(40): 29421 - 29425. [Full Text] [PDF]

This Article Full Text (PDF) All Versions of this Article: 281/35/25001    most recent R600010200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pewzner-Jung, Y. Articles by Futerman, A. H. Search for Related Content PubMed PubMed Citation Articles by Pewzner-Jung, Y. Articles by Futerman, A. H. Social Bookmarking                      What's this?